Analytical Data
-
Gene name
C9
- Application
-
Alternative Names
C9；Complement component C9
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P02748
-
Expression Region
22-559aa
-
AA Sequence
QYTTSYDPELTESSGSASHIDCRMSPWSEWSQCDPCLRQMFRSRSIEVFG QFNGKRCTDAVGDRRQCVPTEPCEDAEDDCGNDFQCSTGRCIKMRLRCNG DNDCGDFSDEDDCESEPRPPCRDRVVEESELARTAGYGINILGMDPLSTP FDNEFYNGLCNRDRDGNTLTYYRRPWNVASLIYETKGEKNFRTEHYEEQI EAFKSIIQEKTSNFNAAISLKFTPTETNKAEQCCEETASSISLHGKGSFR FSYSKNETYQLFLSYSSKKEKMFLHVKGEIHLGRFVMRNRDVVLTTTFVD DIKALPTTYEKGEYFAFLETYGTHYSSSGSLGGLYELIYVLDKASMKRKG VELKDIKRCLGYHLDVSLAFSEISVGAEFNKDDCVKRGEGRAVNITSENL IDDVVSLIRGGTRKYAFELKEKLLRGTVIDVTDFVNWASSINDAPVLISQ KLSPIYNLVPVKMKNAHLKKQNLERAIEDYINEFSVRKCHTCQNGGTVIL MDGKCLCACPFKFEGIACEISKQKISEGLPALEFPNEK
-
Molecular Weight
85 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C9 recombinant protein research is a significant area in the field of molecular biology and biotechnology, focusing on the understanding and application of C9 protein, a crucial component involved in various physiological processes. C9, or complement component 9, plays a vital role in the complement system, which is an integral part of the immune response, helping to opsonize pathogens and facilitate their elimination. The manipulation and study of C9 through recombinant techniques allow researchers to explore its structure-function relationships, post-translational modifications, and interactions with other complement components. As the prevalence of complement system-related diseases, such as autoimmune disorders and inflammatory responses, rises, understanding C9's role can lead to novel therapeutic strategies. Furthermore, the production of C9 recombinant protein in suitable expression systems offers opportunities for high-yield generation for experimental use, including structural studies and potential clinical applications. This advances our understanding of immune regulation and could pave the way for new treatments for diseases linked to complement dysfunction. The ongoing research may also contribute to vaccine development and improve diagnostic tools in immunology. Overall, C9 recombinant protein studies represent a frontier in both fundamental and applied research, bridging gaps in our knowledge of immune mechanisms and presenting opportunities for innovative medical breakthroughs.
